ctDNA Can Flag Pseudoprogression in Melanoma Treated With Immunotherapy – Cancer Network
|
ctDNA Can Flag Pseudoprogression in Melanoma Treated With Immunotherapy
Cancer Network Circulating tumor DNA (ctDNA) can help differentiate what is known as pseudoprogression from true progression of disease in patients with melanoma who are treated with programmed death 1 (PD-1) inhibitors, according to a new study. It also showed that … |
